Main page content

Displaying results 1 - 7 of 7
Publication ID: PEP21-06-02-001
Published:

This guide reviews ways that telehealth modalities can be used to provide treatment for serious mental illness and substance use disorders among adults, distills the research into recommendations for practice, and provides examples of how these recommendations can be implemented.

Publication ID: PEP20-06-02-001
Published:

This guide reviews interventions on treating substance misuse and substance use disorders (SUD) in youth with serious emotional disturbances (SED), distills the research into recommendations for practice, and provides examples of the ways that these recommendations can be implemented.

Publication ID: PEP20-06-03-001
Published:

This guide reviews interventions for people living with substance use and mental disorders who are at risk for or living with HIV. Selected interventions are in alignment with goals of the federal “Ending the HIV Epidemic: A Plan for America” (EHE) initiative.

Publication ID: SMA03-3824
Published:

Designed for organizations that provide services to older adults, this toolkit offers information and materials to help understanding the issues associated with substance misuse and mental illness in older adults. The toolkit also contains materials to educate older adults.

Publication ID: SMA14-4842
Published:

This report discusses a technical expert panel convened to assess research about therapeutic services for youth living in foster care. It reviews the scientific evidence and expert panel input to identify action items and further research needs.

Publication ID: SMA12-4079
Published:

This manual provides guidelines in screening and assessing teens for substance use conditions. It covers confidentiality laws, and screening and assessment in juvenile justice settings. The manual also includes screening and assessment tools.

Publication ID: SMA10-4542
Published:

This manual guides counselors in the use of medications to help clients achieve abstinence from alcohol. It describes how the medications work and whom may benefit. It also presents the side effects of three FDA-approved medications: acamprosate, disulfiram, and naltrexone.